Predict your next investment

Angel Investor (Individual)

See what CB Insights has to offer

Investments

2

About Peter Keen

Peter Keen Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Peter Keen

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Peter Keen in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Peter Keen News

Endomag: Going beyond the horizons

Jul 7, 2017

Endomag: Going beyond the horizons PEOPLE Peter Keen, @ Endomag Endomag: Going beyond the horizons Cancer healthcare company Endomag, founded in 2007 as a spin-out from the University College London (UCL) and the University of Houston, has appointed Peter Keen as non-executive director. Keen will focus on supporting the company as it further extends its international reach. A chartered accountant by trade, Keen has over 30 years’ experience in the management and financing of life science businesses. He founded the technology investment firm Cambridge Innovation Capital and has served on the board of many private and public companies. Currently, Keen is a director of both MRC Technology Limited and  the Biotechnology Growth Trust plc. Previously, he was the senior independent director of Abcam plc and was a co-founder of Chiroscience Group plc, where he led the £102m initial public offering. Keen was also a co-founder of the venture capital firm Merlin Biosciences, and, more recently, venture partner with the technology VC DFJ Esprit. Share Sign up for our newsletter Your e-mail-address is already registered.

Peter Keen Investments

2 Investments

Peter Keen has made 2 investments. Their latest investment was in Small Pharma as part of their Seed on April 4, 2017.

CBI Logo

Peter Keen Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/7/2017

Seed

Small Pharma

$1.03M

Yes

3

11/10/2014

Angel

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/7/2017

11/10/2014

Round

Seed

Angel

Company

Small Pharma

Subscribe to see more

Amount

$1.03M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

3

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.